-
1
-
-
27544472697
-
Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors
-
Espeland MA, O'Leary DH, Terry JG, Morgan T, Evans G, Mudra H. Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors. Curr Control Trials Cardiovasc Med 2005;6:3.
-
(2005)
Curr Control Trials Cardiovasc Med
, vol.6
, pp. 3
-
-
Espeland, M.A.1
O'Leary, D.H.2
Terry, J.G.3
Morgan, T.4
Evans, G.5
Mudra, H.6
-
2
-
-
33846863146
-
Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis
-
Nicholls SJ, Tuzcu EM, Sipahi I, Grasso AW, Schoenhagen P, Hu T, Wolski K, Crowe T, Desai MY, Hazen SL, Kapadia SR, Nissen SE. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA 2007;297: 499-508.
-
(2007)
JAMA
, vol.297
, pp. 499-508
-
-
Nicholls, S.J.1
Tuzcu, E.M.2
Sipahi, I.3
Grasso, A.W.4
Schoenhagen, P.5
Hu, T.6
Wolski, K.7
Crowe, T.8
Desai, M.Y.9
Hazen, S.L.10
Kapadia, S.R.11
Nissen, S.E.12
-
3
-
-
20444371945
-
The target of ezetimibe is niemann-pick C1-Like 1 (NPC1L1)
-
Garcia-Calvo M, Lisnock J, Bull HG, Hawes BE, Burnett DA, Braun MP, Crona JH, Davis HR Jr, Dean DC, Detmers PA, Graziano MP, Hughes M, Macintyre DE, Ogawa A, O'neill KA, Iyer SP, Shevell DE, Smith MM, Tang YS, Makarewicz AM, Ujjainwalla F, Altmann SW, Chapman KT, Thornberry NA. The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1). Proc Natl Acad Sci USA 2005;102:8132-8137.
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, pp. 8132-8137
-
-
Garcia-Calvo, M.1
Lisnock, J.2
Bull, H.G.3
Hawes, B.E.4
Burnett, D.A.5
Braun, M.P.6
Crona, J.H.7
Davis Jr., H.R.8
Dean, D.C.9
Detmers, P.A.10
Graziano, M.P.11
Hughes, M.12
MacIntyre, D.E.13
Ogawa, A.14
O'Neill, K.A.15
Iyer, S.P.16
Shevell, D.E.17
Smith, M.M.18
Tang, Y.S.19
Makarewicz, A.M.20
Ujjainwalla, F.21
Altmann, S.W.22
Chapman, K.T.23
Thornberry, N.A.24
more..
-
4
-
-
34548644843
-
Multiple plasma membrane receptors but not NPC1L1 mediate high-affinity, ezetimibe-sensitive cholesterol uptake into the intestinal brush border membrane
-
Knopfel M, Davies JP, Duong PT, Kvaerno L, Carreira EM, Phillips MC, Ioannou YA, Hauser H. Multiple plasma membrane receptors but not NPC1L1 mediate high-affinity, ezetimibe-sensitive cholesterol uptake into the intestinal brush border membrane. Biochim Biophys Acta 2007;1771:1140-1147.
-
(2007)
Biochim Biophys Acta
, vol.1771
, pp. 1140-1147
-
-
Knopfel, M.1
Davies, J.P.2
Duong, P.T.3
Kvaerno, L.4
Carreira, E.M.5
Phillips, M.C.6
Ioannou, Y.A.7
Hauser, H.8
-
5
-
-
34548620629
-
Class B type i scavenger receptor is responsible for the high affinity cholesterol binding activity of intestinal brush border membrane vesicles
-
Labonte ED, Howles PN, Granholm NA, Rojas JC, Davies JP, Ioannou YA, Hui DY. Class B type I scavenger receptor is responsible for the high affinity cholesterol binding activity of intestinal brush border membrane vesicles. Biochim Biophys Acta 2007;1771:1132-1139.
-
(2007)
Biochim Biophys Acta
, vol.1771
, pp. 1132-1139
-
-
Labonte, E.D.1
Howles, P.N.2
Granholm, N.A.3
Rojas, J.C.4
Davies, J.P.5
Ioannou, Y.A.6
Hui, D.Y.7
-
6
-
-
34548635540
-
Ezetimibe in search of receptor(s)-still a never-ending challenge in cholesterol absorption and transport
-
Spener F. Ezetimibe in search of receptor(s)-still a never-ending challenge in cholesterol absorption and transport. Biochim Biophys Acta 2007;1771: 1113-1116.
-
(2007)
Biochim Biophys Acta
, vol.1771
, pp. 1113-1116
-
-
Spener, F.1
-
7
-
-
26444537961
-
Carotenoid transport is decreased and expression of the lipid transporters SR-BI, NPC1L1, and ABCA1 is downregulated in Caco-2 cells treated with ezetimibe
-
During A, Dawson HD, Harrison EH. Carotenoid transport is decreased and expression of the lipid transporters SR-BI, NPC1L1, and ABCA1 is downregulated in Caco-2 cells treated with ezetimibe. J Nutr 2005;135:2305-2312.
-
(2005)
J Nutr
, vol.135
, pp. 2305-2312
-
-
During, A.1
Dawson, H.D.2
Harrison, E.H.3
-
8
-
-
75749114117
-
Pleiotropic effects with equivalent low-density lipoprotein cholesterol reduction: Comparative study between simvastatin and simvastatin/ezetimibe coadministration
-
Araujo DB, Bertolami MC, Ferreira WP, Abdalla DS, Faludi AA, Nakamura Y, Bricharello LP. Pleiotropic effects with equivalent low-density lipoprotein cholesterol reduction: comparative study between simvastatin and simvastatin/ezetimibe coadministration. J Cardiovasc Pharmacol 2010;55:1-5.
-
(2010)
J Cardiovasc Pharmacol
, vol.55
, pp. 1-5
-
-
Araujo, D.B.1
Bertolami, M.C.2
Ferreira, W.P.3
Abdalla, D.S.4
Faludi, A.A.5
Nakamura, Y.6
Bricharello, L.P.7
-
9
-
-
26044473080
-
Endothelial function in the forearm circulation of patients with the metabolic syndrome-effect of different lipid-lowering regimens
-
Bulut D, Hanefeld C, Bulut-Streich N, Graf C, Mugge A, Spiecker M. Endothelial function in the forearm circulation of patients with the metabolic syndrome-effect of different lipid-lowering regimens. Cardiology 2005;104:176-180.
-
(2005)
Cardiology
, vol.104
, pp. 176-180
-
-
Bulut, D.1
Hanefeld, C.2
Bulut-Streich, N.3
Graf, C.4
Mugge, A.5
Spiecker, M.6
-
10
-
-
33646740966
-
Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: Clinical evidence for 'pleiotropic' functions of statin therapy
-
Fichtlscherer S, Schmidt-Lucke C, Bojunga S, Rossig L, Heeschen C, Dimmeler S, Zeiher AM. Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for 'pleiotropic' functions of statin therapy. Eur Heart J 2006;27:1182-1190.
-
(2006)
Eur Heart J
, vol.27
, pp. 1182-1190
-
-
Fichtlscherer, S.1
Schmidt-Lucke, C.2
Bojunga, S.3
Rossig, L.4
Heeschen, C.5
Dimmeler, S.6
Zeiher, A.M.7
-
11
-
-
77953285918
-
Rosuvastatin but not ezetimibe improves endothelial function in patients with heart failure, by mechanisms independent of lipid lowering
-
Gounari P, Tousoulis D, Antoniades C, Kampoli AM, Stougiannos P, Papageorgiou N, Roulia G, Stefanadi E, Siasos G, Tsioufis C, Stefanadis C. Rosuvastatin but not ezetimibe improves endothelial function in patients with heart failure, by mechanisms independent of lipid lowering. Int J Cardiol 2009;142: 87-91.
-
(2009)
Int J Cardiol
, vol.142
, pp. 87-91
-
-
Gounari, P.1
Tousoulis, D.2
Antoniades, C.3
Kampoli, A.M.4
Stougiannos, P.5
Papageorgiou, N.6
Roulia, G.7
Stefanadi, E.8
Siasos, G.9
Tsioufis, C.10
Stefanadis, C.11
-
12
-
-
77952292502
-
Improved endothelial function with simvastatin but unchanged insulin sensitivity with simvastatin or ezetimibe
-
Kater AL, Batista MC, Ferreira SR. Improved endothelial function with simvastatin but unchanged insulin sensitivity with simvastatin or ezetimibe. Metabolism 2010; 59:921-926.
-
(2010)
Metabolism
, vol.59
, pp. 921-926
-
-
Kater, A.L.1
Batista, M.C.2
Ferreira, S.R.3
-
13
-
-
79953331260
-
Comparative study between high-dose fluvastatin and low-dose fluvastatin and ezetimibe with regard to the effect on endothelial function in diabetic patients
-
Kawagoe Y, Hattori Y, Nakano A, Aoki C, Tanaka S, Ohta S, Iijima T, Tomizawa A, Jojima T, Kase H, Kasai K. Comparative study between high-dose fluvastatin and low-dose fluvastatin and ezetimibe with regard to the effect on endothelial function in diabetic patients. Endocr J 2011;58:171-175.
-
(2011)
Endocr J
, vol.58
, pp. 171-175
-
-
Kawagoe, Y.1
Hattori, Y.2
Nakano, A.3
Aoki, C.4
Tanaka, S.5
Ohta, S.6
Iijima, T.7
Tomizawa, A.8
Jojima, T.9
Kase, H.10
Kasai, K.11
-
14
-
-
20844463066
-
Simvastatin versus ezetimibe: Pleiotropic and lipid-lowering effects on endothelial function in humans
-
Landmesser U, Bahlmann F, Mueller M, Spiekermann S, Kirchhoff N, Schulz S, Manes C, Fischer D, de GK, Fliser D, Fauler G, Marz W, Drexler H. Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans. Circulation 2005;111:2356-2363.
-
(2005)
Circulation
, vol.111
, pp. 2356-2363
-
-
Landmesser, U.1
Bahlmann, F.2
Mueller, M.3
Spiekermann, S.4
Kirchhoff, N.5
Schulz, S.6
Manes, C.7
Fischer, D.8
De, G.K.9
Fliser, D.10
Fauler, G.11
Marz, W.12
Drexler, H.13
-
15
-
-
59049103155
-
Evidence for statin pleiotropy in humans: Differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation
-
Liu PY, Liu YW, Lin LJ, Chen JH, Liao JK. Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation. Circulation 2009; 119:131-138.
-
(2009)
Circulation
, vol.119
, pp. 131-138
-
-
Liu, P.Y.1
Liu, Y.W.2
Lin, L.J.3
Chen, J.H.4
Liao, J.K.5
-
16
-
-
67349105071
-
Flow-mediated dilation in patients with coronary artery disease is enhanced by high dose atorvastatin compared to combined low dose atorvastatin and ezetimibe: Results of the CEZAR study
-
Ostad MA, Eggeling S, Tschentscher P, Schwedhelm E, Boger R, Wenzel P, Meinertz T, Munzel T, Warnholtz A. Flow-mediated dilation in patients with coronary artery disease is enhanced by high dose atorvastatin compared to combined low dose atorvastatin and ezetimibe: results of the CEZAR study. Atherosclerosis 2009;205:227-232.
-
(2009)
Atherosclerosis
, vol.205
, pp. 227-232
-
-
Ostad, M.A.1
Eggeling, S.2
Tschentscher, P.3
Schwedhelm, E.4
Boger, R.5
Wenzel, P.6
Meinertz, T.7
Munzel, T.8
Warnholtz, A.9
-
17
-
-
77954314232
-
Improvement of endothelial damage and regeneration indexes in patients with coronary artery disease after 4 weeks of statin therapy
-
Schmidt-Lucke C, Fichtlscherer S, Rossig L, Kamper U, Dimmeler S. Improvement of endothelial damage and regeneration indexes in patients with coronary artery disease after 4 weeks of statin therapy. Atherosclerosis 2010;211:249-254.
-
(2010)
Atherosclerosis
, vol.211
, pp. 249-254
-
-
Schmidt-Lucke, C.1
Fichtlscherer, S.2
Rossig, L.3
Kamper, U.4
Dimmeler, S.5
-
18
-
-
47649116533
-
Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease
-
Settergren M, Bohm F, Ryden L, Pernow J. Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease. Eur Heart J 2008;29:1753-1760.
-
(2008)
Eur Heart J
, vol.29
, pp. 1753-1760
-
-
Settergren, M.1
Bohm, F.2
Ryden, L.3
Pernow, J.4
-
19
-
-
41649107358
-
Simvastatin with or without ezetimibe in familial hypercholesterolemia
-
Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, Visseren FL, Sijbrands EJ, Trip MD, Stein EA, Gaudet D, Duivenvoorden R, Veltri EP, Marais AD, de GE. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 2008;358:1431-1443.
-
(2008)
N Engl J Med
, vol.358
, pp. 1431-1443
-
-
Kastelein, J.J.1
Akdim, F.2
Stroes, E.S.3
Zwinderman, A.H.4
Bots, M.L.5
Stalenhoef, A.F.6
Visseren, F.L.7
Sijbrands, E.J.8
Trip, M.D.9
Stein, E.A.10
Gaudet, D.11
Duivenvoorden, R.12
Veltri, E.P.13
Marais, A.D.14
De, G.E.15
-
20
-
-
72049129430
-
Extended-release niacin or ezetimibe and carotid intima-media thickness
-
Taylor AJ, Villines TC, Stanek EJ, Devine PJ, Griffen L, Miller M, Weissman NJ, Turco M. Extended-release niacin or ezetimibe and carotid intima-media thickness. N Engl J Med 2009;361:2113-2122.
-
(2009)
N Engl J Med
, vol.361
, pp. 2113-2122
-
-
Taylor, A.J.1
Villines, T.C.2
Stanek, E.J.3
Devine, P.J.4
Griffen, L.5
Miller, M.6
Weissman, N.J.7
Turco, M.8
-
21
-
-
80052094401
-
The effect of ezetimibe on peripheral arterial atherosclerosis depends upon statin use at baseline
-
West AM, Anderson JD, Meyer CH, Epstein FH, Wang H, Hagspiel KD, Berr SS, Harthun NL, Dimaria JM, Hunter JR, Christopher JM, Chew JD, Winberry GB, Kramer CM. The effect of ezetimibe on peripheral arterial atherosclerosis depends upon statin use at baseline. Atherosclerosis 2011;218:156-162.
-
(2011)
Atherosclerosis
, vol.218
, pp. 156-162
-
-
West, A.M.1
Anderson, J.D.2
Meyer, C.H.3
Epstein, F.H.4
Wang, H.5
Hagspiel, K.D.6
Berr, S.S.7
Harthun, N.L.8
Dimaria, J.M.9
Hunter, J.R.10
Christopher, J.M.11
Chew, J.D.12
Winberry, G.B.13
Kramer, C.M.14
-
22
-
-
77953121328
-
The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis): Final results and the impact of medication adherence, dose, and treatment duration
-
Villines TC, Stanek EJ, Devine PJ, Turco M, Miller M, Weissman NJ, Griffen L, Taylor AJ. The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis): final results and the impact of medication adherence, dose, and treatment duration. J Am Coll Cardiol 2010;55:2721-2726.
-
(2010)
J Am Coll Cardiol
, vol.55
, pp. 2721-2726
-
-
Villines, T.C.1
Stanek, E.J.2
Devine, P.J.3
Turco, M.4
Miller, M.5
Weissman, N.J.6
Griffen, L.7
Taylor, A.J.8
-
23
-
-
34249304476
-
Design and rationale of the ARBITER 6 trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol-6-HDL and LDL Treatment Strategies in Atherosclerosis (HALTS)
-
Devine PJ, Turco MA, Taylor AJ. Design and rationale of the ARBITER 6 trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol)-6-HDL and LDL Treatment Strategies in Atherosclerosis (HALTS). Cardiovasc Drugs Ther 2007;21:221-225.
-
(2007)
Cardiovasc Drugs Ther
, vol.21
, pp. 221-225
-
-
Devine, P.J.1
Turco, M.A.2
Taylor, A.J.3
-
24
-
-
38549168453
-
Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe-statin therapies on noncholesterol sterols in patients with primary hypercholesterolemia
-
Assmann G, Kannenberg F, Ramey DR, Musliner TA, Gutkin SW, Veltri EP. Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe-statin therapies on noncholesterol sterols in patients with primary hypercholesterolemia. Curr Med Res Opin 2008;24:249-259.
-
(2008)
Curr Med Res Opin
, vol.24
, pp. 249-259
-
-
Assmann, G.1
Kannenberg, F.2
Ramey, D.R.3
Musliner, T.A.4
Gutkin, S.W.5
Veltri, E.P.6
-
25
-
-
30844437481
-
Inhibition of cholesterol absorption by the combination of dietary plant sterols and ezetimibe: Effects on plasma lipid levels
-
Jakulj L, Trip MD, Sudhop T, von BK, Kastelein JJ, Vissers MN. Inhibition of cholesterol absorption by the combination of dietary plant sterols and ezetimibe: effects on plasma lipid levels. J Lipid Res 2005;46: 2692-2698.
-
(2005)
J Lipid Res
, vol.46
, pp. 2692-2698
-
-
Jakulj, L.1
Trip, M.D.2
Sudhop, T.3
Von, B.K.4
Kastelein, J.J.5
Vissers, M.N.6
-
26
-
-
77954320146
-
Ezetimibe alone or in combination with simvastatin increases small dense lowdensity lipoproteins in healthy men: A randomized trial
-
Berneis K, Rizzo M, Berthold HK, Spinas GA, Krone W, Gouni-Berthold I. Ezetimibe alone or in combination with simvastatin increases small dense lowdensity lipoproteins in healthy men: a randomized trial. Eur Heart J 2010;31: 1633-1639.
-
(2010)
Eur Heart J
, vol.31
, pp. 1633-1639
-
-
Berneis, K.1
Rizzo, M.2
Berthold, H.K.3
Spinas, G.A.4
Krone, W.5
Gouni-Berthold, I.6
-
27
-
-
33646073444
-
Effect of ezetimibe on low-density lipoprotein subtype distribution: Results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins
-
Geiss HC, Otto C, Parhofer KG. Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins. Metabolism 2006; 55:599-604.
-
(2006)
Metabolism
, vol.55
, pp. 599-604
-
-
Geiss, H.C.1
Otto, C.2
Parhofer, K.G.3
-
28
-
-
0037196569
-
The identification of intestinal scavenger receptor class B, type i (SR-BI) by expression cloning and its role in cholesterol absorption
-
Altmann SW, Davis HR Jr., Yao X, Laverty M, Compton DS, Zhu LJ, Crona JH, Caplen MA, Hoos LM, Tetzloff G, Priestley T, Burnett DA, Strader CD, Graziano MP. The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption. Biochim Biophys Acta 2002;1580:77-93.
-
(2002)
Biochim Biophys Acta
, vol.1580
, pp. 77-93
-
-
Altmann, S.W.1
Davis Jr., H.R.2
Yao, X.3
Laverty, M.4
Compton, D.S.5
Zhu, L.J.6
Crona, J.H.7
Caplen, M.A.8
Hoos, L.M.9
Tetzloff, G.10
Priestley, T.11
Burnett, D.A.12
Strader, C.D.13
Graziano, M.P.14
-
29
-
-
36348975228
-
Effects of torcetrapib in patients at high risk for coronary events
-
Barter PJ, Caulfield M, Eriksson M, Grundy SM, Kastelein JJ, Komajda M, Lopez-Sendon J, Mosca L, Tardif JC, Waters DD, Shear CL, Revkin JH, Buhr KA, Fisher MR, Tall AR, Brewer B. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 2007;357:2109-2122.
-
(2007)
N Engl J Med
, vol.357
, pp. 2109-2122
-
-
Barter, P.J.1
Caulfield, M.2
Eriksson, M.3
Grundy, S.M.4
Kastelein, J.J.5
Komajda, M.6
Lopez-Sendon, J.7
Mosca, L.8
Tardif, J.C.9
Waters, D.D.10
Shear, C.L.11
Revkin, J.H.12
Buhr, K.A.13
Fisher, M.R.14
Tall, A.R.15
Brewer, B.16
-
30
-
-
34247241088
-
Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia
-
Kastelein JJ, van Leuven SI, Burgess L, Evans GW, Kuivenhoven JA, Barter PJ, Revkin JH, Grobbee DE, RileyWA, Shear CL, Duggan WT, Bots ML. Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia. N Engl J Med 2007;356:1620-1630.
-
(2007)
N Engl J Med
, vol.356
, pp. 1620-1630
-
-
Kastelein, J.J.1
Van Leuven, S.I.2
Burgess, L.3
Evans, G.W.4
Kuivenhoven, J.A.5
Barter, P.J.6
Revkin, J.H.7
Grobbee, D.E.8
Riley, W.A.9
Shear, C.L.10
Duggan, W.T.11
Bots, M.L.12
-
31
-
-
79959746706
-
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): A randomised placebo-controlled trial
-
Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C,Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellstrom B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de ZD, Gronhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet 2011;377: 2181-2192.
-
(2011)
Lancet
, vol.377
, pp. 2181-2192
-
-
Baigent, C.1
Landray, M.J.2
Reith, C.3
Emberson, J.4
Wheeler, D.C.5
Tomson Cwanner, C.6
Krane, V.7
Cass, A.8
Craig, J.9
Neal, B.10
Jiang, L.11
Hooi, L.S.12
Levin, A.13
Agodoa, L.14
Gaziano, M.15
Kasiske, B.16
Walker, R.17
Massy, Z.A.18
Feldt-Rasmussen, B.19
Krairittichai, U.20
Ophascharoensuk, V.21
Fellstrom, B.22
Holdaas, H.23
Tesar, V.24
Wiecek, A.25
Grobbee, D.26
De, Z.D.27
Gronhagen-Riska, C.28
Dasgupta, T.29
Lewis, D.30
Herrington, W.31
Mafham, M.32
Majoni, W.33
Wallendszus, K.34
Grimm, R.35
Pedersen, T.36
Tobert, J.37
Armitage, J.38
Baxter, A.39
Bray, C.40
Chen, Y.41
Chen, Z.42
Hill, M.43
Knott, C.44
Parish, S.45
Simpson, D.46
Sleight, P.47
Young, A.48
Collins, R.49
more..
|